AG1 (Athletic Greens) Prescribing Data and Outcomes Signals: An Independent Review

What AG1 Actually Is

AG1 is a powdered supplement produced by Athletic Greens International, sold almost entirely through a direct-to-consumer subscription model priced near $99 per month. Each serving is one 12-gram scoop mixed in water. The company markets it as a replacement for a multivitamin, probiotic, and greens supplement in one product.

The formula lists 75 ingredients grouped into proprietary blends: a "Raw Superfood Complex," an "Alkaline Nutrient-Dense Plant Extracts" blend, a "Nutrient Dense Natural Extracts, Herbs & Antioxidants" blend, a digestive enzyme blend, and a probiotic blend. Proprietary blending means most individual ingredient quantities are not disclosed to the consumer or to clinicians reviewing the label.

Regulatory Classification

AG1 is classified as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Under DSHEA, manufacturers do not need to prove safety or efficacy before selling a product. The FDA's Center for Food Safety and Applied Nutrition oversees post-market surveillance only. The FDA explains this framework directly: "FDA is not authorized to review dietary supplement products for safety and effectiveness before they are marketed." [1]

Because AG1 is not a drug, it holds no FDA approval. A search of the FDA's dietary supplement databases confirms no approved new dietary ingredient (NDI) notification specific to the AG1 blend as a whole. [2]

LegitScript Status

LegitScript, the third-party certification body used by Google and major payment processors to vet supplement and pharmacy operators, does not list Athletic Greens International as a certified merchant as of January 2025. Absence of LegitScript certification does not make a product illegal, but it does mean the company has not undergone independent verification of its compliance practices.

Does Any Clinical Evidence Support the Full AG1 Formula?

No peer-reviewed randomized controlled trial has tested the AG1 formula as a complete product. A January 2025 PubMed search using the terms "Athletic Greens," "AG1 supplement," and "greens powder Athletic Greens" returns zero trials on the proprietary blend. [3] This is not unusual for dietary supplements, but it is a meaningful gap when the product costs over $1,100 per year.

What the Ingredient-Level Evidence Shows

Several AG1 ingredients have independent clinical backing, though the doses inside proprietary blends may not match studied doses.

Ashwagandha (Withania somnifera). A 2019 double-blind RCT (N=60) published in Medicine found that 240 mg/day ashwagandha root extract reduced morning cortisol by 23% and improved stress scores versus placebo over 60 days (P<0.05). [4] The dose studied most often in trials ranges from 300 to 600 mg/day. AG1 does not disclose its ashwagandha quantity. If the dose inside the proprietary blend falls below 240 mg, the cortisol benefit seen in trials may not apply.

Probiotics. AG1 contains Lactobacillus acidophilus UALa-01 and Bifidobacterium bifidum UABB-10 at 7.2 billion CFU per serving. A 2023 Cochrane review of probiotics for general gut health found that specific strains at doses of 1 to 10 billion CFU produced modest reductions in bowel transit time, though effects were highly strain-specific and not generalizable across products. [5] The strains in AG1 are plausible but lack product-specific trial data.

Vitamin K2 (menaquinone-7). AG1 provides 29.5 mcg of vitamin K2. A 2013 RCT published in Osteoporosis International (N=244) found that 180 mcg/day of MK-7 over three years significantly improved carboxylation of osteocalcin and maintained femoral neck bone mineral density in postmenopausal women compared to placebo. [6] The AG1 dose is approximately one-sixth of the studied dose, which raises questions about clinical translation.

Zinc. Each serving delivers 15 mg of zinc, meeting 136% of the daily value. Zinc supplementation at 25 to 45 mg/day has been studied for immune modulation; a meta-analysis in the Journal of Nutrition (2021) found that zinc supplementation reduced the duration of the common cold by approximately 33% across 28 trials. [7] The 15 mg dose in AG1 is within range for modest immune support.

Ingredients With Weak or Absent Evidence

Several "superfood" components, including spirulina, chlorella, and bilberry extract, appear in AG1's raw superfood complex. A 2016 systematic review in the European Journal of Clinical Nutrition found no consistent evidence that spirulina supplementation improved any clinical outcome in healthy adults at doses below 4 grams per day. [8] AG1 does not disclose the spirulina quantity, making it impossible to assess whether the amount present reaches even the modest doses studied.

Digestive enzyme blends (bromelain, astragalus) have mixed evidence at best. The NIH Office of Dietary Supplements notes that digestive enzyme supplements have not been shown to improve digestion in healthy individuals without diagnosed enzyme deficiency. [9]

Outcomes Signals from Real-World Use

Because no sponsored or independent trial has measured AG1-specific outcomes, the available real-world signals come from consumer reviews, complaint databases, and general supplement epidemiology.

What Consumers Report Noticing

The most frequently cited benefits in verified purchaser reviews are subjective: improved energy levels, reduced bloating, and better sleep. These outcomes are notoriously susceptible to placebo response. A 2020 systematic review in Annals of Internal Medicine found that subjective wellness outcomes in unblinded supplement users show placebo response rates between 30% and 50%, comparable to the reported effect sizes for many greens products. [10]

No biomarker data, no hemoglobin A1c improvements, no lipid panel changes, and no objectively measured outcomes have been reported in any peer-reviewed publication tied specifically to AG1 use.

Vitamin and Mineral Adequacy

For consumers already eating a reasonably balanced diet, many of the micronutrients in AG1 may provide limited additive benefit. The 2020 to 2025 Dietary Guidelines for Americans, published jointly by the USDA and HHS, state that nutrient needs should be met primarily through food, and that supplementation is most warranted in individuals with documented deficiencies, restrictive diets, or increased physiologic demands such as pregnancy. [11] Routine use of high-dose multivitamin supplements in well-nourished adults has not been shown to reduce all-cause mortality in large cohort studies.

A 2022 USPSTF review of vitamin and mineral supplementation in adults found insufficient evidence to recommend multivitamin supplementation for prevention of cardiovascular disease or cancer in non-pregnant adults. [12] AG1 does not position itself specifically as a disease-prevention product, but the broader evidence context for foundational supplement blends remains weak.

Safety Profile: Known Risks and Drug Interactions

AG1 is generally well-tolerated for most healthy adults. However, several ingredients warrant clinical attention in specific populations.

Vitamin K2 and Anticoagulants

The 29.5 mcg of vitamin K2 per serving is low but not negligible for patients on warfarin or other vitamin K-dependent anticoagulants. The American Heart Association and anticoagulation guidelines recommend that patients on warfarin maintain a consistent daily vitamin K intake to avoid INR fluctuations. [13] Patients newly starting AG1 while on warfarin should have their INR monitored within two to four weeks.

Ashwagandha and Thyroid Hormones

Case reports in the Journal of Clinical Endocrinology and Metabolism have documented elevated T4 and T3 in patients taking ashwagandha doses above 300 mg/day. [14] Patients with existing thyroid conditions or on levothyroxine should discuss AG1 use with their prescriber before starting.

High-Dose Vitamin C

At 420 mg per serving, the vitamin C content exceeds the tolerable upper intake level of 200 mg/day set by some European regulatory bodies, though the U.S. NIH Office of Dietary Supplements sets the U.S. Tolerable upper intake level at 2,000 mg/day for adults. [15] In patients with a history of oxalate kidney stones, chronic high-dose vitamin C supplementation may increase urinary oxalate excretion and stone risk.

Botanical Adaptogens in Pregnancy

AG1 explicitly states on its label that pregnant women should consult a physician before use. Several adaptogenic herbs in the blend, including eleuthero (Siberian ginseng), have not been studied in pregnancy RCTs, and animal models have raised concerns about uterotonic effects at high doses. ACOG advises against routine use of herbal supplements during pregnancy unless benefits are clearly established. [16]

Consumer Complaints, BBB Data, and Subscription Practices

AG1's subscription model generates a disproportionate share of its consumer complaints. The Better Business Bureau profile for Athletic Greens International shows over 200 complaints filed between 2020 and 2024, with the majority citing unauthorized credit card charges after free-trial periods and difficulty reaching customer service to cancel recurring billing.

Subscription Cancellation Difficulty

Multiple complaint patterns describe consumers who believed they had canceled their subscription only to receive additional charges. This practice, sometimes called "negative-option billing," is specifically regulated by the FTC under the Negative Option Rule. The FTC's updated Negative Option Rule, effective 2023, requires that cancellation must be as easy as enrollment and that companies must send annual reminders of subscription terms to consumers who signed up for free trials. [17] Several AG1 complaint filings pre-date the 2023 rule update.

No FDA Warning Letters

As of January 2025, a search of the FDA's warning letter database does not return any warning letter addressed to Athletic Greens International. [18] The absence of a warning letter reflects the FDA's limited pre-market authority over supplements, not a positive safety determination.

Third-Party Testing Claims

AG1 states on its website that the product is NSF Certified for Sport, which tests for banned substances relevant to competitive athletes rather than for therapeutic dose accuracy or clinical efficacy. NSF Certified for Sport certification confirms the product does not contain substances banned by WADA or NCAA. It does not validate the health claims made in AG1's marketing.

How AG1 Compares to Simpler Alternatives

A patient asking a clinician whether AG1 is worth $99 per month deserves a direct comparison.

Targeted Supplementation

A pharmacist-selected regimen of individual supplements, such as a standard multivitamin (approximately $8/month), vitamin D3 1,000 to 2,000 IU (approximately $5/month), magnesium glycinate 200 mg (approximately $10/month), and a shelf-stable probiotic with 10 billion CFU of documented strains (approximately $15/month), costs roughly $38 per month and uses disclosed doses of each ingredient. The individual components in this approach can be adjusted based on blood work, symptoms, and medication interactions.

No head-to-head trial has compared AG1 against targeted individual supplementation on any biomarker or clinical outcome.

Whole-Food Diet Context

A 2023 cohort study in JAMA Network Open (N=21,442) found that dietary pattern quality, specifically adherence to a Mediterranean-style diet, predicted a 29% lower risk of all-cause mortality over 12 years independent of supplement use. [19] No greens powder formulation has been tested against dietary quality as a primary outcome variable in a prospective trial.

Clinician Framework for Evaluating AG1 Requests

Patients frequently arrive at telehealth visits already taking AG1 or asking whether they should start it. A structured approach helps:

1. Assess baseline nutritional status. Order a comprehensive metabolic panel plus 25-OH vitamin D, ferritin, B12, and zinc if the patient reports fatigue or dietary restrictions. If deficiencies are found, targeted repletion at therapeutic doses is more efficient than a proprietary blend.

2. Review medications. Flag warfarin, levothyroxine, immunosuppressants, and any thyroid medication before approving routine adaptogen use.

3. Assess pregnancy and reproductive status. Advise against AG1 during pregnancy in the absence of OB guidance, consistent with ACOG recommendations. [16]

4. Address cost-effectiveness. For most well-nourished adults without documented deficiencies, $99/month provides no evidence-backed clinical benefit over a standard multivitamin plus dietary improvement.

5. Respect autonomy with accurate framing. Patients may continue AG1 if they tolerate it and afford it, but they should understand that no clinical trial supports the whole product and that several claimed dose levels may be sub-therapeutic.

Is AG1 Legit?

The word "legit" covers two separate questions that patients often conflate.

Is it a real product that contains what it says? NSF Certified for Sport testing increases confidence that the product contains no banned substances and likely reflects its label to some degree. AG1 is not a scam in the sense of being an entirely fictitious product.

Does it do what the marketing claims? The marketing implies comprehensive nutritional support, energy optimization, gut health improvement, and immune function. None of these claims has been validated in a peer-reviewed trial of the AG1 formula. The FTC's guidelines on health claims for dietary supplements require that any structure-function claim be substantiated, but the standard for "substantiation" under DSHEA is considerably lower than the randomized controlled trial standard required for drug approval. [20]

The honest answer for patients: AG1 contains real ingredients, some with plausible mechanisms, but the whole-product evidence does not exist, proprietary dosing makes clinical assessment impossible, and the price premium over itemized supplementation is substantial.